Hepatitis B in Canada: the case for universal vaccination. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
出版信息
CMAJ. 1992 Jan 1;146(1):25-8.
Abstract
摘要
相似文献
1
2
Universal hepatitis B vaccination: the economics of prevention.
CMAJ. 1992 Jan 1;146(1):19-21.
3
Universal vaccination against hepatitis B.
CMAJ. 1992 Jan 1;146(1):36.
4
Control of hepatitis B: to be or not to be?
Pediatrics. 1992 Aug;90(2 Pt 1):274-7.
5
[Vaccination against hepatitis B in Switzerland: towards a global strategy].
Rev Med Suisse Romande. 1998 Apr;118(4):335-9.
6
[The costs of hepatitis B vaccination: a re-evaluation].
Ned Tijdschr Geneeskd. 1990 Feb 10;134(6):298-301.
7
American Academy of Pediatrics Committee on Infectious Diseases: Universal hepatitis B immunization.
Pediatrics. 1992 Apr;89(4 Pt 2):795-800.
8
Model based analysis of hepatitis B vaccination strategies in the Netherlands.
Vaccine. 2009 Feb 18;27(8):1254-60. doi: 10.1016/j.vaccine.2008.12.009. Epub 2008 Dec 30.
9
Hepatitis B: update on perinatal management. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
CMAJ. 1986 Apr 15;134(8):883-6.
10
National advisory committee on immunization (NACI). Statement on hepatitis B vaccine.
Can Commun Dis Rep. 1993 Jul 30;19(14):104-15.
引用本文的文献
1
Moving towards a universal hepatitis B vaccine program for Canadian children.
Can J Infect Dis. 1995 May;6(3):129-30. doi: 10.1155/1995/605787.
2
Viral hepatitis: retrospective review in a canadian pediatric hospital.
ISRN Pediatr. 2011;2011:182964. doi: 10.5402/2011/182964. Epub 2010 Dec 29.
3
Pediatric immunization for the 1990s.
Can J Infect Dis. 1992 Jan;3(1):6-7. doi: 10.1155/1992/838160.
4
Prevention of perinatal hepatitis B virus transmission in an obstetric/infant population.
Can J Infect Dis. 1993 Sep;4(5):288-91. doi: 10.1155/1993/986932.
5
Targeted versus universal vaccination against hepatitis B: A paradigm shift.
Can J Infect Dis. 1993 May;4(3):171-2. doi: 10.1155/1993/421580.
6
Measuring hepatitis B uptake in a new universal infant program.
Can J Public Health. 2002 Jul-Aug;93(4):281-4. doi: 10.1007/BF03405017.
7
Pharmacoeconomics of immunisation: a review.
Pharmacoeconomics. 1993 Apr;3(4):286-308. doi: 10.2165/00019053-199303040-00005.
8
School-based hepatitis B immunization program: follow-up of non-participants at first school clinic.
Can J Public Health. 1997 May-Jun;88(3):192-6. doi: 10.1007/BF03403886.
本文引用的文献
1
Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal).
Lancet. 1981 Feb 7;1(8215):289-92. doi: 10.1016/s0140-6736(81)91908-5.
2
Hepatitis B vaccine in infants from an endemic area: long-term anti-HBs persistence and revaccination.
J Med Virol. 1987 Aug;22(4):315-21. doi: 10.1002/jmv.1890220404.
3
Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal).
J Med Virol. 1987 May;22(1):1-5. doi: 10.1002/jmv.1890220102.
4
Are booster doses of hepatitis B vaccine necessary?
Ann Intern Med. 1988 Mar;108(3):457-8. doi: 10.7326/0003-4819-108-3-457.
5
Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.
N Engl J Med. 1986 Jul 24;315(4):209-14. doi: 10.1056/NEJM198607243150401.
6
Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).
Lancet. 1986 Nov 15;2(8516):1143-5. doi: 10.1016/s0140-6736(86)90543-x.
7
Hepatitis B virus infection among children born in the United States to Southeast Asian refugees.
N Engl J Med. 1989 Nov 9;321(19):1301-5. doi: 10.1056/NEJM198911093211905.
8
Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population.
JAMA. 1989 Apr 28;261(16):2362-6.
9
The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.
JAMA. 1990 Mar 2;263(9):1218-22.
10
Hepatitis B: global importance and need for control.
Vaccine. 1990 Mar;8 Suppl:S18-20; discussion S21-3. doi: 10.1016/0264-410x(90)90209-5.
Zotero 插件